{"transactions":[{"id":740039,"issuer":{"id":5757,"kind":"organization","name":"Lyell Immunopharma, Inc.","symbol":"LYEL"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2026-06-12T20:19:19.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":9250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option shares shall vest on the earlier of (a) the date of the next annual meeting of the stockholders that occurs following June 10, 2026 (or the date immediately prior to such date if the Reporting Person's service as a director ends at such annual meeting due to the\nReporting Person's failure to be reelected or the Reporting Person not standing for re-election); or (b) the first anniversary of June 10, 2026, subject to the Reporting Person providing continuous service through such date."}],"balance_after":9250,"derivative":{"exercise_price":13.22,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":9250},"source":{"system":"sec-edgar","filing":"0001411874-26-000002","document":"form4-06122026_080616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1806952/000141187426000002/form4-06122026_080616.xml","form_type":"4"}},{"id":1142915,"issuer":{"id":5757,"kind":"organization","name":"Lyell Immunopharma, Inc.","symbol":"LYEL"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2025-05-19T22:47:00.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shares shall vest on the earlier of (a) the date of the next annual meeting of the stockholders that occurs following May 15, 2025 (or the date immediately prior to such date if the Reporting Person's service as a director ends at such annual meeting due to the Reporting Person's failure to be reelected or the Reporting Person not standing for re-election); or (b) the first anniversary of May 15, 2025, subject to the Reporting Person providing continuous service through such date."}],"balance_after":130000,"derivative":{"exercise_price":0.4017,"expiration_date":"2035-05-14","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001415889-25-013712","document":"form4-05192025_100556.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1806952/000141588925013712/form4-05192025_100556.xml","form_type":"4"}},{"id":1477389,"issuer":{"id":5757,"kind":"organization","name":"Lyell Immunopharma, Inc.","symbol":"LYEL"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2024-06-17T20:05:21.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shares shall vest on the earlier of (a) the date of the next annual meeting of the stockholders that occurs following June 14, 2024 (or the date immediately prior to such date if the Reporting Person's service as a director ends at such annual meeting due to the Reporting Person's failure to be reelected or the Reporting Person not standing for re-election); or (b) the first anniversary of June 14, 2024, subject to the Reporting Person providing continuous service through such date."}],"balance_after":130000,"derivative":{"exercise_price":2.36,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001415889-24-017146","document":"form4-06172024_080617.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1806952/000141588924017146/form4-06172024_080617.xml","form_type":"4"}},{"id":1784765,"issuer":{"id":5757,"kind":"organization","name":"Lyell Immunopharma, Inc.","symbol":"LYEL"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2023-09-08T20:26:04.000Z","date":"2023-09-08","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"On September 6, 2023, to align with benchmarking data, the issuer's Compensation Committee amended the Non-Employee Director Compensation Policy to increase the annual equity grant to non-employee directors. The Reporting Person was granted an option to purchase 65,000 shares on June 16, 2023, prior to the amendment of the policy. This additional option grant aligns the Reporting Person's total 2023 grants with the updated policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option shares shall vest on the earlier of (a) the date of the next annual meeting of the stockholders that occurs following June 16, 2023 (or the date immediately prior to such date if the Reporting Person's service as a director ends at such annual meeting due to the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election); or (b) the first anniversary of June 16, 2023, subject to the Reporting Person providing continuous service through such date"}],"balance_after":55000,"derivative":{"exercise_price":3.19,"expiration_date":"2033-09-07","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001209191-23-048785","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1806952/000120919123048785/doc4.xml","form_type":"4"}},{"id":1849694,"issuer":{"id":5757,"kind":"organization","name":"Lyell Immunopharma, Inc.","symbol":"LYEL"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2023-06-20T20:43:41.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shares shall vest on the earlier of (a) the date of the next annual meeting of the stockholders that occurs following June 16, 2023 (or the date immediately prior to such date if the Reporting Person's service as a director ends at such annual meeting due to the Reporting Person's failure to be reelected or the Reporting Person not standing for re-election); or (b) the first anniversary of June 16, 2023, subject to the Reporting Person\nproviding continuous service through such date."}],"balance_after":65000,"derivative":{"exercise_price":3.19,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-23-038437","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1806952/000120919123038437/doc4.xml","form_type":"4"}},{"id":1852393,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-17T01:15:34.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":34735,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the option vest on the earlier of (i) June 14, 2024 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":34735,"derivative":{"exercise_price":4.33,"expiration_date":"2033-06-14","underlying":"Class A Common Stock","underlying_shares":34735},"source":{"system":"sec-edgar","filing":"0001209191-23-038186","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000120919123038186/doc4.xml","form_type":"4"}},{"id":1852392,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-06-17T01:15:34.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":23443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 14, 2024 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":173574,"source":{"system":"sec-edgar","filing":"0001209191-23-038186","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000120919123038186/doc4.xml","form_type":"4"}},{"id":2185537,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-15T16:17:09.000Z","date":"2022-08-15","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":3.6,"value":36000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, these options automatically vested and were cancelled, by virtue of the Merger and without any action on the part of the Reporting Person, and the Reporting Person was entitled to receive (without interest) (A) an amount in cash (less applicable Tax withholdings) equal to the product of (x) the total number of Shares subject to such option immediately prior to the effective time multiplied by (y) the excess, if any, of the Cash Consideration over the applicable exercise price per Share under such option, and (B) one CVR for each Share subject thereto."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, these options automatically vested and were cancelled, by virtue of the Merger and without any action on the part of the Reporting Person, and the Reporting Person was entitled to receive (without interest) (A) an amount in cash (less applicable Tax withholdings) equal to the product of (x) the total number of Shares subject to such option immediately prior to the effective time multiplied by (y) the excess, if any, of the Cash Consideration over the applicable exercise price per Share under such option, and (B) one CVR for each Share subject thereto."}],"balance_after":0,"derivative":{"exercise_price":6.4,"expiration_date":"2032-01-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-22-028642","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000089924322028642/doc4.xml","form_type":"4"}},{"id":2185536,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-15T16:17:09.000Z","date":"2022-08-15","kind":"disposition_to_issuer","acquired":false,"shares":26800,"price":10,"value":268000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Merger Agreement, as of the Effective Time, these shares were converted into the right to receive the consideration per Share of (i) $10.00, payable to the holder thereof of cash, without interest but subject to reduction for any applicable withholding Taxes payable in respect thereof, and (ii) one CVR per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Merger Agreement, as of the Effective Time, these shares were converted into the right to receive the consideration per Share of (i) $10.00, payable to the holder thereof of cash, without interest but subject to reduction for any applicable withholding Taxes payable in respect thereof, and (ii) one CVR per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-028642","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000089924322028642/doc4.xml","form_type":"4"}},{"id":2228004,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T22:28:37.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":29640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the option vest on the earlier of (i) June 15, 2023 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":29640,"derivative":{"exercise_price":7.33,"expiration_date":"2031-06-15","underlying":"Class A Common Stock","underlying_shares":29640},"source":{"system":"sec-edgar","filing":"0001209191-22-038080","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000120919122038080/doc4.xml","form_type":"4"}},{"id":2228003,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-06-17T22:28:37.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":9945,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 15, 2023 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":150131,"source":{"system":"sec-edgar","filing":"0001209191-22-038080","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000120919122038080/doc4.xml","form_type":"4"}},{"id":2236198,"issuer":{"id":5757,"kind":"organization","name":"Lyell Immunopharma, Inc.","symbol":"LYEL"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2022-06-10T20:09:41.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shares shall vest on the earlier of (a) the date of the next annual meeting of the stockholders that occurs following June 8, 2022 (or the date immediately prior to such date if the Reporting Person's service as a director ends at such annual meeting due to the Reporting Person's failure to be reelected or the Reporting Person not standing for re-election); or (b) the first anniversary of June 8, 2022, subject to the Reporting Person\nproviding continuous service through such date."}],"balance_after":65000,"derivative":{"exercise_price":5.31,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-22-035837","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1806952/000120919122035837/doc4.xml","form_type":"4"}},{"id":2426588,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-25T16:30:38.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the grant date, subject to continued service with RDUS through such date."}],"balance_after":10000,"derivative":{"exercise_price":6.4,"expiration_date":"2032-01-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-22-004785","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919122004785/doc4.xml","form_type":"4"}},{"id":2426587,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-25T16:30:38.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were acquired pursuant to a restricted stock unit award under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of RDUS common stock. The restricted stock units vest in full on the first anniversary of the award date, subject to continued service with RDUS through such date."}],"balance_after":26800,"source":{"system":"sec-edgar","filing":"0001209191-22-004785","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919122004785/doc4.xml","form_type":"4"}},{"id":2473707,"issuer":{"id":5757,"kind":"organization","name":"Lyell Immunopharma, Inc.","symbol":"LYEL"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-14T21:57:45.000Z","date":"2021-12-14","kind":"other","acquired":true,"shares":218722,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"MSL FBO J DUANE & C FRIEDMAN TTEE DUANE FAMILY TRUST"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Received in a pro-rata distribution from Lyell Investors, LLC.  The Reporting Person is a trustee of MSL FBO J DUANE & C FRIEDMAN TTEE DUANE FAMILY TRUST (\"Duane Family Trust\") and therefore may be deemed to share the power to direct the disposition and vote of the shares held by the Duane Family Trust. The Reporting Person disclaims beneficial ownership of all shares held by Duane Family Trust except to any pecuniary interest therein."}],"balance_after":236370,"source":{"system":"sec-edgar","filing":"0001209191-21-069485","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806952/000120919121069485/doc4.xml","form_type":"4"}},{"id":2473706,"issuer":{"id":5757,"kind":"organization","name":"Lyell Immunopharma, Inc.","symbol":"LYEL"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-14T21:57:45.000Z","date":"2021-12-14","kind":"other","acquired":false,"shares":3765842,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Lyell Investors, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Pro-rata distribution by Lyell Investors, LLC to its members."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-069485","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806952/000120919121069485/doc4.xml","form_type":"4"}},{"id":2657485,"issuer":{"id":5757,"kind":"organization","name":"Lyell Immunopharma, Inc.","symbol":"LYEL"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2021-06-23T21:33:13.000Z","date":"2021-06-21","kind":"exercise","acquired":false,"shares":3765842,"ownership":{"direct":false,"nature":"Lyell Investors, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Issuer's Series A Convertible Preferred Stock converted into Common Stock on a 1-for-1 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's Series A Convertible Preferred Stock converted into Common Stock on a 1-for-1 basis and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Issuer's Series A Convertible Preferred Stock converted into Common Stock on a 1-for-1 basis and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Issuer's Series A Convertible Preferred Stock converted into Common Stock on a 1-for-1 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a member of Lyell Investors, LLC and therefore may be deemed to share the power to direct the disposition and vote of\nthe shares held by Lyell Investors, LLC. The Reporting Person disclaims beneficial ownership of all shares held by Lyell Investors, LLC except to\nany pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3765842},"source":{"system":"sec-edgar","filing":"0001209191-21-042795","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1806952/000120919121042795/doc4.xml","form_type":"4"}},{"id":2657484,"issuer":{"id":5757,"kind":"organization","name":"Lyell Immunopharma, Inc.","symbol":"LYEL"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-23T21:33:13.000Z","date":"2021-06-21","kind":"purchase","acquired":true,"shares":17648,"price":17,"value":300016.0,"ownership":{"direct":false,"nature":"MSL FBO J DUANE & C FRIEDMAN TTEE DUANE FAMILY TRUST"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is a trustee of MSL FBO J DUANE & C FRIEDMAN TTEE\nDUANE FAMILY TRUST (\"Duane Family Trust\") and therefore may be deemed to share the power to direct the disposition and vote of the shares held by the Duane Family Trust. The Reporting Person disclaims beneficial ownership of all shares held by Duane Family Trust except to any pecuniary interest therein."}],"balance_after":17648,"source":{"system":"sec-edgar","filing":"0001209191-21-042795","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806952/000120919121042795/doc4.xml","form_type":"4"}},{"id":2657483,"issuer":{"id":5757,"kind":"organization","name":"Lyell Immunopharma, Inc.","symbol":"LYEL"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-23T21:33:13.000Z","date":"2021-06-21","kind":"exercise","acquired":true,"shares":3765842,"ownership":{"direct":false,"nature":"Lyell Investors, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's Series A Convertible Preferred Stock converted into Common Stock on a 1-for-1 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a member of Lyell Investors, LLC and therefore may be deemed to share the power to direct the disposition and vote of\nthe shares held by Lyell Investors, LLC. The Reporting Person disclaims beneficial ownership of all shares held by Lyell Investors, LLC except to\nany pecuniary interest therein."}],"balance_after":3765842,"source":{"system":"sec-edgar","filing":"0001209191-21-042795","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806952/000120919121042795/doc4.xml","form_type":"4"}},{"id":2658937,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-22T22:23:43.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 17, 2022 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":33.74,"expiration_date":"2031-06-17","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-042500","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000120919121042500/doc4.xml","form_type":"4"}},{"id":2839104,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-23T17:48:33.000Z","date":"2021-02-22","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the grant date, subject to continued service with RDUS through such date."}],"balance_after":10000,"derivative":{"exercise_price":18.6,"expiration_date":"2031-02-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-013332","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919121013332/doc4.xml","form_type":"4"}},{"id":2839103,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-23T17:48:33.000Z","date":"2021-02-22","kind":"grant","acquired":true,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were acquired pursuant to a restricted stock unit award under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of RDUS common stock. The restricted stock units vest in full on the first anniversary of the award date, subject to continued service with RDUS through such date."}],"balance_after":21300,"source":{"system":"sec-edgar","filing":"0001209191-21-013332","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919121013332/doc4.xml","form_type":"4"}},{"id":2897577,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-25T17:04:03.000Z","date":"2021-01-21","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on the first anniversary of the grant date or upon an earlier Change of Control (as defined in the registrant's 2018 Stock Option and Incentive Plan)."}],"balance_after":20000,"derivative":{"exercise_price":22,"expiration_date":"2031-01-21","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-005111","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919121005111/doc4.xml","form_type":"4"}},{"id":2948750,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-12T02:10:47.000Z","date":"2020-12-03","kind":"grant","acquired":true,"shares":18691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 36 equal monthly installments beginning on January 3, 2021."}],"balance_after":18691,"derivative":{"exercise_price":19,"expiration_date":"2020-12-03","underlying":"Class A Common Stock","underlying_shares":18691},"source":{"system":"sec-edgar","filing":"0001628280-20-017428","document":"wf-form4_160773903250913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000162828020017428/wf-form4_160773903250913.xml","form_type":"4"}},{"id":3252774,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-24T18:28:58.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on February 20, 2021, subject to continued service with RDUS through such date."}],"balance_after":10000,"derivative":{"exercise_price":19.96,"expiration_date":"2030-02-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-012186","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919120012186/doc4.xml","form_type":"4"}},{"id":3252773,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-24T18:28:58.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were acquired pursuant to a restricted stock unit award under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of RDUS common stock. The restricted stock units vest in full on February 20, 2021, subject to continued service with RDUS through such date."}],"balance_after":15800,"source":{"system":"sec-edgar","filing":"0001209191-20-012186","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919120012186/doc4.xml","form_type":"4"}},{"id":3631887,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-26T18:13:06.000Z","date":"2019-02-22","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on February 22, 2020, subject to continued service with RDUS through such date."}],"balance_after":10000,"derivative":{"exercise_price":19.18,"expiration_date":"2029-02-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-013699","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919119013699/doc4.xml","form_type":"4"}},{"id":3631886,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-26T18:13:06.000Z","date":"2019-02-22","kind":"grant","acquired":true,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were acquired pursuant to a restricted stock unit award under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of RDUS common stock. The restricted stock units vest in full on February 22, 2020, subject to continued service with RDUS through such date."}],"balance_after":10300,"source":{"system":"sec-edgar","filing":"0001209191-19-013699","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919119013699/doc4.xml","form_type":"4"}},{"id":3660237,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-02-13T17:16:57.000Z","date":"2019-02-13","kind":"exercise","acquired":false,"shares":4800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of RDUS common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vested in full on February 13, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vested in full on February 13, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4800},"source":{"system":"sec-edgar","filing":"0001209191-19-009734","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919119009734/doc4.xml","form_type":"4"}},{"id":3660236,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-13T17:16:57.000Z","date":"2019-02-13","kind":"exercise","acquired":true,"shares":4800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of RDUS common stock."}],"balance_after":4800,"source":{"system":"sec-edgar","filing":"0001209191-19-009734","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919119009734/doc4.xml","form_type":"4"}},{"id":4054647,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-02-15T19:37:41.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":4800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of RDUS common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in full on February 13, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in full on February 13, 2019."}],"balance_after":4800,"derivative":{"underlying":"Common Stock","underlying_shares":4800},"source":{"system":"sec-edgar","filing":"0001209191-18-010544","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919118010544/doc4.xml","form_type":"4"}},{"id":4054646,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-15T19:37:41.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":8800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on February 13, 2019, subject to continued service to the Issuer through such date."}],"balance_after":8800,"derivative":{"exercise_price":37.83,"expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":8800},"source":{"system":"sec-edgar","filing":"0001209191-18-010544","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919118010544/doc4.xml","form_type":"4"}},{"id":4281373,"issuer":{"id":13268,"kind":"organization","name":"ALTABA INC.","symbol":"AABA"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true}}],"security":"Cash-Settled Restricted Stock Units","published_at":"2017-06-15T19:39:04.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":8545,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each cash-settled restricted stock unit is the economic equivalent of one share of Altaba Inc. common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents amendment of the Reporting Person's outstanding restricted stock unit awards (the acquisition of which was previously reported in Table I of Form 4) under the issuer's Directors' Stock Plan, changing the awards' terms from stock-settlement to cash-settlement."}],"balance_after":8545,"derivative":{"exercise_price":0,"exercise_date":"2020-09-01","expiration_date":"2020-09-01","underlying":"Common Stock","underlying_shares":8545},"source":{"system":"sec-edgar","filing":"0001127602-17-021498","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1011006/000112760217021498/form4.xml","form_type":"4"}},{"id":4281372,"issuer":{"id":13268,"kind":"organization","name":"ALTABA INC.","symbol":"AABA"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-06-15T19:39:04.000Z","date":"2017-06-13","kind":"disposition_to_issuer","acquired":false,"shares":8545,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents amendment of the Reporting Person's outstanding restricted stock unit awards (the acquisition of which was previously reported in Table I of Form 4) under the issuer's Directors' Stock Plan, changing the awards' terms from stock-settlement to cash-settlement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-17-021498","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1011006/000112760217021498/form4.xml","form_type":"4"}},{"id":4346840,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-24T21:24:07.000Z","date":"2017-04-20","kind":"grant","acquired":true,"shares":19857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\").  100% of the RSUs will vest at the sooner of the next annual shareholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":73805,"source":{"system":"sec-edgar","filing":"0001179110-17-006175","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000117911017006175/edgar.xml","form_type":"4"}},{"id":4431344,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":38772,"kind":"person","name":"FRIEDMAN CATHY","position":1,"cik":"0001411874","reported_name":"FRIEDMAN CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-22T16:24:59.000Z","date":"2017-02-17","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on February 17, 2018, subject to continued service to the Issuer through such date."}],"balance_after":27500,"derivative":{"exercise_price":45.65,"expiration_date":"2027-02-16","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001209191-17-013241","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919117013241/doc4.xml","form_type":"4"}}]}